BioHarvest Sciences Inc. Common Stock
NASDAQ:BHSTAgricultural Inputs
+$0.08 today
- Market cap
- $50.25M
- Beta
- 1.33
- P/E (TTM)
- -6.6
- EPS (TTM)
- -$0.50
Volume 0.01M
Average 0.03M
BHST Net Change in Cash
Combined operating, investing, financing, and currency effects on the cash balance during the period.
BioHarvest Sciences Inc. Common StockNASDAQ: BHST
Net Change in Cash · Q1 FY2026 · quarter ended Mar 2026
Net change in cash turns negative
Q1 FY2026 net change in cash was -$3.86M, compared with $1.01M a year earlier. Trailing-twelve-month net change in cash was $15.77M.
Context
- Net change in cash amounted to 59.8% of revenue in FY2025, up 48.0 pp from a year earlier.
- Net change in cash increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly net change in cash holds near -$3.86M or moves back toward the trailing-twelve-month quarterly average of $3.94M.
Sources:Cash FlowText generated from reported figures; not investment advice.
Net Change in Cash history
USD · from the cash flow
- Latest · FY2025
- 20.64M USD
- Year-over-year change
- +796.0%
- 4-year CAGR
- +72.4%
| Period | Period end | Net Change in Cash | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 20.64M | +796.0% |
| FY2024 | 2024-12-31 | (2.97M) | -181.9% |
| FY2023 | 2023-12-31 | 3.62M | +252.0% |
| FY2022 | 2022-12-31 | (2.38M) | -202.0% |
| FY2021 | 2021-12-31 | 2.33M | — |
Net Change in Cash vs competitors
How BHST compares with its peers on the latest reported figures
- BHST's LTM Mar 2026 net change in cash of $15.77M is the 6th largest of the 9 companies compared; the peer median is $2.52M.
- Its year-over-year change of +45145.7% is the highest of 8, against a peer median of -28.2%.
- Net change in cash amounts to 44.8% of revenue for BHST, versus a peer median of 7.8%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $91.93M | -0.9% | -39.3% | 5.0% | |
| LTM Mar 2026 | $74.7M | -28.2% | — | 67.8% | |
| LTM Mar 2026 | $59.11M | +3204.5% | — | 11.3% | |
| LTM Mar 2026 | $33.55M | +158.6% | — | 43.8% | |
| LTM Mar 2026 | $20.97M | -217.4% | +24.0% | 7.7% | |
| LTM Mar 2026 | $15.77M | +45145.7% | — | 44.8% | |
| LTM May 2025 | $4.11M | -1351.5% | -51.7% | 7.8% | |
USGOU.S. GoldMining Inc. | LTM Feb 2026 | $1.71M | — | — | — |
| LTM Mar 2026 | $923K | -47.2% | -55.9% | 0.1% | |
| Peer median (excluding BHST) | $2.52M | -28.2% | -45.5% | 7.8% | |
Competitors are the stored peer set for BHST. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (9.83M) | (11.24M) | (12.56M) | (12.91M) | (11.14M) |
| Depreciation & Amortization | 385.58K | 712K | 840K | 1.25M | 1.62M |
| Deferred Income Tax | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 3.37M | 1.35M | 563K | 601K | 597K |
| Change in Working Capital | (96K) | (308K) | 755K | (555K) | (1.94M) |
| Accounts Receivables | (266K) | (588K) | (22K) | (594K) | (1.11M) |
| Inventory | (828K) | (450K) | (1.09M) | (1.19M) | (904K) |
| Accounts Payables | 0 | 730K | 0 | 1.04M | 0 |
| Other Working Capital | 998K | 0 | 1.87M | 188K | 67K |
| Other Non-Cash Items | (627K) | 239K | 1.88M | 4.93M | 3.63M |
| Operating Cash Flow | (6.79M) | (9.24M) | (8.52M) | (6.68M) | (7.23M) |
| Capital Expenditures | (1.64M) | (1.26M) | (1.47M) | (2.84M) | (2.36M) |
| Acquisitions (Net) | 0 | 0 | 0 | 0 | 0 |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 0 | 0 | 0 | (192K) | (10K) |
| Investing Cash Flow | (1.64M) | (1.26M) | (1.47M) | (3.03M) | (2.37M) |
| Debt Repayment | (332K) | 7.3M | 13.15M | 2.04M | 5.25M |
| Common Stock Issued | 7.47M | 877K | 534.17K | 4.33M | 25.1M |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 3.64M | (38K) | (131.17K) | 408K | (159K) |
| Financing Cash Flow | 10.77M | 8.14M | 13.56M | 6.78M | 30.19M |
| Effect of Forex Changes | (4K) | (22K) | 59K | (34K) | 39K |
| Net Change in Cash | 2.33M | (2.38M) | 3.62M | (2.97M) | 20.64M |
| Free Cash Flow | (8.43M) | (10.5M) | (10M) | (9.52M) | (9.58M) |
BioHarvest Sciences Inc. Common Stock
NASDAQ:BHST
Intrinsic Alpha fair value
Locked
Current Price
$2.90
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.